A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer

The present work was supported by the CA72851, CA181572, CA184792, and CA187956 grants from the National Cancer Institute, National Institute of Health; RP140784 from the Cancer Prevention Research Institute of Texas; grants from the Sammons Cancer Center and Baylor Foundation, as well as funds from...

Descripción completa

Detalles Bibliográficos
Autores: Okuno, Keisuke, Kandimalla, Raju, Mendiola, Marta, Balaguer, Francesc, Bujanda Fernández de Pierola, Luis, Fernández Martos, Carlos, Aparicio, Jorge, Feliú, Jaime, Tokunaga, Masanori, Kinugasa, Yusuke, Maurel, Joan, Goel, Ajay
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad del País Vasco
Repositorio:Addi. Archivo Digital para la Docencia y la Investigación
OAI Identifier:oai:addi.ehu.eus:10810/59988
Acceso en línea:http://hdl.handle.net/10810/59988
Access Level:acceso abierto
Palabra clave:colorectal cancer
microRNA
predictive biomarker
adjuvant chemotherapy
FOLFOX
Descripción
Sumario:The present work was supported by the CA72851, CA181572, CA184792, and CA187956 grants from the National Cancer Institute, National Institute of Health; RP140784 from the Cancer Prevention Research Institute of Texas; grants from the Sammons Cancer Center and Baylor Foundation, as well as funds from the Baylor Research Institute, Dallas, TX, USA awarded to Ajay Goel. The present work was also supported by Catalan Agency for Management of University and Research Grants (AGAUR) (2014-SGR-474 and 2017-SGR-1174), Fundació la Marató de TV3 (201330.10), Instituto de Salud Carlos III (PI13/01728 and PI19/00740) and Fundacion Olga Torres (Modalitat A. 2019/2020) to Joan Maurel.

Similares en LA Referencia